Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Allurion Technologies Inc (ALUR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Allurion Tech's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.975 -0.155    -7.28%
10/05 - Closed. Currency in USD ( Disclaimer )
After Hours
1.990
+0.015
+0.759%
21:10:00 - Real-time Data
  • Volume: 71,845
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.930 - 2.100
Type:  Equity
Market:  United States
Allurion Tech 1.975 -0.155 -7.28%

Allurion Tech Company Profile

 
Read the Allurion Technologies Inc company profile to learn more about the business and the management team. View Allurion Technologies Inc facts about employee data, company products and services, and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

268

Equity Type

ORD

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Contact Information

Address 11 Huron Drive
Natick, 01760
United States
Phone 508 647 4000
Fax -

Top Executives

Name Age Since Title
Peter D. Siersma - - Medical Advisor
Krishna K. Gupta 36 - Independent Co-Chairman
Michael R. Davin 66 - Independent Director
Larson Douglas Hudson 54 - Independent Director
Robert S. Langer 74 2022 Chairman of Scientific Advisory Board
Shantanu K. Gaur 37 2009 Co-Founder, CEO, President & Director
Jaime Ponce - - Medical Advisor
Harold S. Solomon - - Medical Advisor
Jordan Busch - - Medical Advisor
Nezam H. Afdhal 67 - Medical Advisor
Nicholas S. Lewin 46 - Independent Director
Bruce Schirmer - - Medical Advisor
Richard I. Rothstein - - Medical Advisor
Regina Barzilay - 2023 Member of Scientific Advisory Board
John Morton - - Medical Advisor
E.M.H. Mathus-Vliegen - - Medical Advisor
Milena Alberti-Perez 51 2024 Independent Director
S. Omar Ishrak 68 - Co-Chairman & Lead Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALUR Price Commentary

Write your thoughts about Allurion Technologies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email